Infectious Disease Treatments Companies
Infectious disease treatment is a critical area of focus for pharmaceutical and biotechnology companies, especially in the development of medications, vaccines, and other therapeutic interventions.
Infectious disease treatment is a critical area of focus for pharmaceutical and biotechnology companies, especially in the development of medications, vaccines, and other therapeutic interventions.
Pfizer and Gilead remain dominant players: These pharmaceutical giants hold a combined 62% share of the market, driven by their strong portfolios of vaccines and antiviral drugs.
Moderna expands beyond COVID-19: The company announces positive Phase 2 trial results for its cytomegalovirus (CMV) vaccine candidate, potentially setting the stage for a new market entry.
Novartis receives FDA approval for Lutforal (brexafolmab) for invasive aspergillosis: This new antifungal medication offers an alternative treatment option for this serious fungal infection.
Antibiotic development sees renewed focus: Companies like Entasis Therapeutics and Achaogen are developing novel antibiotics against resistant bacteria, addressing a critical unmet need.
PwC Legal LLC: Introduced their PwC CLEAR eDiscovery platform in January 2024, providing a comprehensive eDiscovery solution with built-in data privacy and security features for healthcare clients.
List of Infectious Disease Treatments Key companies in the market:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)